FOLD Stock Summary and Trading Ideas (Amicus Therapeutics | NASDAQ:FOLD)

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Amicus Therapeutics trades on the NASDAQ stock market under the symbol FOLD.

As of April 19, 2024, FOLD stock price climbed to $10.61 with 2,382,177 million shares trading.

FOLD has a beta of 1.48, meaning it tends to be more sensitive to market movements. FOLD has a correlation of 0.20 to the broad based SPY ETF.

FOLD has a market cap of $3.08 billion. This is considered a Mid Cap stock.

Last quarter Amicus Therapeutics reported $115 million in Revenue and $.01 earnings per share. This beat revenue expectation by $745,000 and exceeded earnings estimates by $.07.

In the last 3 years, FOLD stock traded as high as $14.57 and as low as $5.91.

The top ETF exchange traded funds that FOLD belongs to (by Net Assets): VTI, VB, IWM, XBI, VBK.

FOLD has underperformed the market in the last year with a price return of -9.2% while the SPY ETF gained +21.2%. FOLD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.8% and -9.5%, respectively, while the SPY returned +3.0% and -4.5%, respectively.

FOLD support price is $10.10 and resistance is $10.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FOLD stock will trade within this expected range on the day.